Auckland Clinical Studies is taking strict measures to ensure the health and safety of patients, carers, participants and staff during the Coronavirus pandemic:
ACS provides high quality, cost-effective, Phase I and II clinical research to local and international pharmaceutical and biotechnology companies. ACS conducts healthy volunteer (including FIH) and patient studies; ACS works across all specialty areas with a particular focus on liver disease. The common theme for service provision is excellence of study and quality assurance at a competitive cost. ACS is able to offer full and tailored CRO services when required from protocol development to clinical study report.
- Clinical Study Conduct and trial design consulting Read More
- Full service support available through experienced partners
- Medical writing
- Monitoring
- Biostatistics
- Bioanalytics
- Data management
- Full service support available through experienced partners
- Patient recruitment across different therapeutic areas
- Pharmacist services Read More
- Biomarker assay implementation (through partner labs) Read More
- onsite PBMC processing
- Regulatory Consulting Read More
- ACS can act as local agent acting on behalf of Sponsors for regulatory submissions
- Quality Management and GCP training Read More
